Latest Breaking News On - System order - Page 3 : comparemela.com

About Nexstim Plc Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain. SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.

Eteläuomen läiUnited statesMikko karvinenNexstim plcNexstim or companyPress releaseSystem orderNewtherapy customerMajor depressive disorderNavigated brain therapyNavigated brain stimulationNasdaq first north growth market finlandNasdaq first north growth marketHelsinki stock exchange nxtmhNexstim oyjDepression treatment